Skip to main content
Top
Published in: Obesity Surgery 4/2015

01-04-2015 | Original Contributions

Changes in Glucose Transporters, Gluconeogenesis, and Circadian Clock after Duodenal–Jejunal Bypass Surgery

Authors: Mikyung Kim, Young Gil Son, Yu Na Kang, Tae Kyung Ha, Eunyoung Ha

Published in: Obesity Surgery | Issue 4/2015

Login to get access

Abstract

Background

Bariatric surgery improves obesity and ameliorates glucose tolerance. This study was conducted to evaluate circadian clocks, gluconeogenesis, and glucose transport changes in hepatic and intestinal tissues after duodenal–jejunal bypass (DJB) surgery in a rat model.

Methods

Twenty-five rats were randomly assigned to either sham group (10 rats) or DJB group (15 rats). Food intake, body weight, blood glucose, and serum insulin levels were measured. Quantitative RT-PCR, immunoblot, and immunohistochemistry were used to analyze genes and proteins in the liver and intestine.

Results

Food intake and body weight were not different between sham and DJB groups. Blood glucose level was significantly lower in the DJB group compared with that in the sham group. Although not significant, serum insulin level showed an increased tendency in DJB group. DJB induced marked expressions of glucose transporter-2 (GLUT2) in the liver and GLUT2 and sodium-dependent glucose transporter-1 (SGLT1) in the intestine. Gluconeogenic enzymes [phosphoenolpyruvate carboxykinase-1 (Pck1) and glucose-6-phosphatase (G6Pase)] decreased in the liver and increased in the intestine of the DJB group. Circadian transcription factor cryptochrome-1 (Cry1) increased in the liver and decreased in the intestine of the DJB group. Another circadian transcription factor period-2 (Per2) also increased in the liver and decreased in the intestine of the DJB group.

Conclusion

In conclusion, this study suggests the possibility that Cry1 and Per2 may mediate decreased gluconeogenesis in the liver and increased gluconeogenesis in the intestine of the DJB group.
Literature
1.
go back to reference Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMed
2.
go back to reference Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.CrossRefPubMed Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.CrossRefPubMed
3.
go back to reference Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.CrossRefPubMedCentralPubMed Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.CrossRefPubMedCentralPubMed
4.
go back to reference Cummings DE, Overduin J, Foster-Schubert KE, et al. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis. 2007;3:109–15.CrossRefPubMedCentralPubMed Cummings DE, Overduin J, Foster-Schubert KE, et al. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis. 2007;3:109–15.CrossRefPubMedCentralPubMed
5.
go back to reference Moo TA, Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15:153–8.CrossRefPubMed Moo TA, Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15:153–8.CrossRefPubMed
6.
go back to reference Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518–25.CrossRefPubMed Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518–25.CrossRefPubMed
7.
go back to reference Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab. 2008;8:201–11.CrossRefPubMed Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab. 2008;8:201–11.CrossRefPubMed
8.
go back to reference Mithieux G. A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition. 2009;25:881–4.CrossRefPubMed Mithieux G. A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition. 2009;25:881–4.CrossRefPubMed
9.
go back to reference Quercia I, Dutia R, Kotler DP. Gastrointestinal changes after bariatric surgery. Diabetes Metab. 2014;40:87–94.CrossRefPubMed Quercia I, Dutia R, Kotler DP. Gastrointestinal changes after bariatric surgery. Diabetes Metab. 2014;40:87–94.CrossRefPubMed
10.
go back to reference Li B, Lu Y, Srikant CB, et al. Intestinal adaptation and Reg gene expression induced by antidiabetic duodenal–jejunal bypass surgery in Zucker fatty rats. Am J Physiol Gastrointest Liver Physio. 2013;304:G635–45.CrossRef Li B, Lu Y, Srikant CB, et al. Intestinal adaptation and Reg gene expression induced by antidiabetic duodenal–jejunal bypass surgery in Zucker fatty rats. Am J Physiol Gastrointest Liver Physio. 2013;304:G635–45.CrossRef
11.
go back to reference Saeidi N, Meoli L, Nestoridi E, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science. 2013;341:406–10.CrossRefPubMedCentralPubMed Saeidi N, Meoli L, Nestoridi E, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science. 2013;341:406–10.CrossRefPubMedCentralPubMed
13.
go back to reference Hoogerwerf WA, Hellmich HL, Cornelissen G, et al. Clock gene expression in the murine gastrointestinal tract: endogenous rhythmicity and effects of a feeding regimen. Gastroenteology. 2007;133:1250–60.CrossRef Hoogerwerf WA, Hellmich HL, Cornelissen G, et al. Clock gene expression in the murine gastrointestinal tract: endogenous rhythmicity and effects of a feeding regimen. Gastroenteology. 2007;133:1250–60.CrossRef
14.
go back to reference Hatori M, Panda S. CRY links the circadian clock and CREB-mediated gluconeogenesis. Cell Res. 2010;20:1285–8.CrossRefPubMed Hatori M, Panda S. CRY links the circadian clock and CREB-mediated gluconeogenesis. Cell Res. 2010;20:1285–8.CrossRefPubMed
15.
16.
go back to reference Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.CrossRefPubMedCentralPubMed Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.CrossRefPubMedCentralPubMed
17.
go back to reference Mingrone G, Panunzi S, Gaetano AD, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.CrossRefPubMed Mingrone G, Panunzi S, Gaetano AD, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.CrossRefPubMed
18.
go back to reference Moriya R, Shirakura T, Ito J, et al. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. Am J Physiol Endocrinol Metab. 2009;297:E1358–65.CrossRefPubMed Moriya R, Shirakura T, Ito J, et al. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. Am J Physiol Endocrinol Metab. 2009;297:E1358–65.CrossRefPubMed
19.
go back to reference Jurowich CF, Rikkala PR, Thalheimer A, et al. Duodenal–jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes. Ann Surg. 2013;258:89–97.CrossRefPubMed Jurowich CF, Rikkala PR, Thalheimer A, et al. Duodenal–jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes. Ann Surg. 2013;258:89–97.CrossRefPubMed
20.
go back to reference Yan S, Sun F, Li Z, et al. Reduction of intestinal electrogenic glucose absorption after duodenojejunal bypass in a mouse mode. Obes Surg. 2013;23:1361–9.CrossRefPubMed Yan S, Sun F, Li Z, et al. Reduction of intestinal electrogenic glucose absorption after duodenojejunal bypass in a mouse mode. Obes Surg. 2013;23:1361–9.CrossRefPubMed
21.
go back to reference Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal–jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med. 2012;18:950–5.CrossRefPubMed Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal–jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med. 2012;18:950–5.CrossRefPubMed
Metadata
Title
Changes in Glucose Transporters, Gluconeogenesis, and Circadian Clock after Duodenal–Jejunal Bypass Surgery
Authors
Mikyung Kim
Young Gil Son
Yu Na Kang
Tae Kyung Ha
Eunyoung Ha
Publication date
01-04-2015
Publisher
Springer US
Published in
Obesity Surgery / Issue 4/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1434-4

Other articles of this Issue 4/2015

Obesity Surgery 4/2015 Go to the issue